Thursday, July 2, 2009

CDER New July 1, 2009

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

July 1, 2009

June 29, 2009


Visit Drugs@FDA to search Drug Approval Reports by Month. 

New and Generic Drug Approvals

July 1, 2009

  • Abraxane (paclitaxel) I.V. Suspension, Abraxis BioScience, Inc., Labeling Revision
  • Azithromycin Injection, Hospira, Inc., Approval
  • Cetirizine Hydrochloride Allergy Tablets, Unichem Laboratories, Ltd., Approval
  • Cipro (ciprofloxacin hydrochloride) Tablets, Bayer Pharmaceuticals Corp., Labeling Revision
  • Cipro (ciprofloxacin) Injection, Bayer Pharmaceuticals Corp., Labeling Revision
  • Cipro in Dextrose 5% in Plastic Contanier (ciprofloxacin) , Bayer Pharmaceuticals Corp., Labeling Revision
  • Cipro (ciprofloxacin) Oral Suspension, Bayer Pharmaceuticals Corp., Labeling Revision
  • Cipro XR (ciprofloxacin and ciprofloxacin hydrochloride) Extended-Release Tablets, Bayer Pharmaceuticals Corp., Labeling Revision
  • Dorzolamide Hydrochloride Ophthalmic Solution, Bausch & Lomb, Inc., Approval
  • Finasteride Tablets, Sun Pharmaceutical Industries Ltd., Approval
  • Lupron Depot-Ped (leuprolide acetate) Injection, Abbott Laboratories, Labeling Revision
  • Montelukast Sodium Chewable Tablets, Mylan Pharmaceuticals Inc., Tentative Approval
  • Montelukast Sodium Tablets, Teva Pharmaceuticals, Tentative Approval
  • Oxcarbazepine Oral Suspension, Ranbaxy Laboratories Ltd., Approval
  • Tev-Tropin (somatropin [rDNA origin] Injection, Ferring Pharmaceuticals, Control Supplement
  • Tygacil (tigecycline) I.V. Injection, Wyeth Pharmaceuticals Inc., Package Change


Manage your FDA Subscriptions:

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

0 comments: